EFFICACY AND SAFETY OF ELUXADOLINE IN IBS-D PATIENTS WHO REPORT INADEQUATE SYMPTOM CONTROL WITH PRIOR LOPERAMIDE USE: A PHASE 4, MULTICENTER, MULTINATIONAL, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED STUDY (RELIEF)
Darren M Brenner 1
Catherine R. Gutman 2
Esther Jo 3
Steven Elmes 2
1 Feinberg School of Medicine, Northwestern Memorial Hospital,Chicago,United States
2 Allergan plc,Madison,United States
3 Allergan plc,Irvine,United States
Conference
UEG Week 2018
Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
Social Sharing